Chairman and CEO
Edwards Lifesciences Corporation
Michael A. Mussallem is chairman and chief executive officer of
Edwards Lifesciences Corporation, the global leader in the science of
heart valves and hemodynamic monitoring. Driven by a passion to help
patients, the company partners with clinicians to develop innovative
technologies in the areas of structural heart disease and critical care
monitoring that enable them to save and enhance lives.
Michael A. Mussallem has been chairman and chief executive officer
since 2000 when the company spun-off from Baxter International. Prior to
his current position, Mussallem held a variety of positions with
increasing responsibility in engineering, product development and senior
management at Baxter, including group vice president of its
cardiovascular business from 1994 to 2000 and group vice president of
the biopharmaceutical business from 1998 to 2000. From 1996 until 1998,
he was the chairman of Baxter’s Asia board overseeing Baxter’s
operations throughout Asia. Previously, he worked for Union Carbide.
Mussallem is the former chairman of the board of directors of the
Advanced Medical Technology Association (AdvaMed). He is currently on
the boards and executive committees of AdvaMed, California Healthcare
Institute and OCTANe, and is a trustee of the University of California,
Irvine Foundation. Mussallem received a bachelor’s degree in chemical
engineering and an honorary doctorate degree from the Rose-Hulman
Institute of Technology in Terre Haute, Indiana.